Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Therapeutic insights into he treatment of stroke, multiple sclerosis, and Alzheimer’s disease: Argonaute-2 promotes neuroprotection via up regulation of its target gene, 24/September/2014, 6.31 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at firstname.lastname@example.org
Significance: This study suggests that Argonaute-2, by up regulating the expression of its target gene, it may promote survival of Neurons. Thus, pharmacological formulations encompassing “Argonaute-2 activator” may be used to treat: (1) hypoxic-ischemic brain injury ; (2) Stroke; (3) Multiple sclerosis; and (4) Alzhemer’s disease.
* Research cooperation